file_name,case_name,docket_number,Argued,Decided,first_party,first_party_label,second_party,second_party_label,winning_party,decision_type,majority_vote,minority_vote,william_h_rehnquist,john_paul_stevens,sandra_day_oconnor,antonin_scalia,anthony_m_kennedy,david_h_souter,clarence_thomas,ruth_bader_ginsburg,stephen_g_breyer,advocate_ID_0,advocate_0,advocate_description_0,advocate_ID_1,advocate_1,advocate_description_1,advocate_ID_2,advocate_2,advocate_description_2,advocate_ID_4,advocate_4,advocate_description_4
2002.01-188,Pharmaceutical Research & Manufacturers of America v. Walsh,01-188,1043215200,1053320400,Pharmaceutical Research & Manufacturers of America,Petitioner,Walsh,Respondent,Walsh,majority opinion,6,3,minority,majority,minority,majority,minority,majority,majority,majority,majority,22617,edwin_s_kneedler,"Department of Justice, argued the cause for the United States, as amicus curiae",19760,carter_g_phillips,Argued the cause for the petitioner,16248,andrew_s_hagler,"Augusta, Maine, argued the cause for the respondents",42179,sheldon_v_toubman,for Legal Services Organizations Representing Medicaid Beneficiaries as amicus curiae
